Prostate Cancer Hormone Therapy Tied to Dementia, Depression in Younger Men
Findings from a recent study emphasize the importance of neurocognitive assessment in men undergoing ADT, especially in younger patients, according to investigators.
Findings from a recent study emphasize the importance of neurocognitive assessment in men undergoing ADT, especially in younger patients, according to investigators.
Anticholinergics have been the main class of oral medications used to treat overactive bladder, but providers’ prescribing patterns have changed in light of research linking these medications to an increased risk for dementia, according to a new survey.
Those with higher-risk episodes for ESRD as young adults had poorer cognitive performance at midlife.
In a large population-based study, individuals with sustained hypertension in midlife to late life had a 49% increased risk of subsequent dementia compared with those who remained normotensive.
Rate of memory decline 3.9 percent slower in those with, versus those without, cancer diagnosis
In type 2 diabetes patients, a dementia diagnosis preceded vascular events such as kidney disease progression by a mean 2998 days or roughly 8 years.
Androgen deprivation therapy for prostate cancer is associated with a 22% increased of any dementia and 29% increased risk of Alzheimer’s disease.
According to the authors, the influence of midlife hypetertension may lead to late-life impaired cognitive function.
Mild cognitive impairment and progression to dementia has been linked to metabolic syndrome, according to JAMA Neurology.
Greater additional risk for women with diabetes for vascular, but not nonvascular, dementia.